Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
Business Wire•04/08/2026•16:02 ET
0
Whiz Insights
Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
Launched pharmaceutical program targeting rare genetic diseases and aging related disorders in July
Get started
Create a free account to read the full story.